IP Library Granted Patent US 8,652,816
Granted Patent B2
US 8,652,816 · App. 13/284,337 · Granted Feb 18, 2014

Compositions and methods for 3-hydroxypropionate bio-production from biomass

Inventor: Michael D. Lynch (Boulder, CO)
Assignee: OPX Biotechnologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,816
App. No.
13/284,337
Granted
Feb 18, 2014
Kind
B2
Abstract

Methods of obtaining mutant nucleic acid sequences that demonstrate elevated oxaloacetate α-decarboxylase activity are provided. Compositions, such as genetically modified microorganisms that comprise such mutant nucleic acid sequences, are described, as are methods to obtain the same.

Claims (25)

1. A method for producing an acrylic acid-based consumer product, said method comprising the steps of:

i) combining a carbon source and a cell culture to produce 3-hydroxypropionic acid, wherein said cell culture comprises a genetically modified Escherichia coli ( E. coli ) microorganism comprising a heterologous nucleic acid encoding for a protein with malonyl-CoA reductase activity; and wherein said genetically modified E. coli microorganism further comprises reduction in activity of pyruvate formate-lyase;

ii) growing said cell culture in feed-batch, batch mode, or continuous batch mode production;

iii) converting said 3-hydroxypropionic acid to acrylic acid;

iv) polymerizing acrylic acid into a polymer of acrylate; and

v) processing said polymer of acrylate into a consumer product.

2. The method of claim 1 , wherein said microorganism is further modified for increased tolerance to 3-hydroxypropionic acid.

3. The method of claim 1 , wherein said genetically modified E. coli microorganism further comprises reduction in activity of lactate dehydrogenase, phosphate acetyltransferase, and pyruvate oxidase.

4. The method of claim 1 , wherein said genetically modified E. coli microorganism further comprises a modification in a malonyl-CoA reductase enzyme, wherein the malonyl-CoA reductase enzyme comprises a molecule with at least 90% sequence identity to SEQ ID NO: 11.

5. A consumer product produced according to the following steps:

i) combining a carbon source and a cell culture to produce 3-hydroxypropionic acid, wherein said cell culture comprises a genetically modified Escherichia coil microorganism comprising a heterologous nucleic acid encoding for a protein with malonyl-CoA reductase activity; and wherein said genetically modified E. coli microorganism further comprises reduction in activity of pyruvate formate-lyase;

ii) growing said cell culture in feed-batch, batch mode, or continuous batch mode production;

iii) converting said 3-hydroxypropionic acid to acrylic acid;

iv) polymerizing acrylic acid into a polymer of acrylate;and

v) processing said polymer of acrylate into a consumer product.

6. The method of claim 1 , wherein the polymer of acrylate is selected from the group consisting of methyl acrylate, butyl acrylate, ethyl acrylate, and polyacrylic acid.

7. The method of claim 1 , wherein the polymer of acrylate is butyl acrylate.

8. The method of claim 1 , wherein the polymer of acrylate is ethyl acrylate.

9. The method of claim 1 , wherein the consumer product is selected from the group consisting of: paints, coatings, plastics, adhesives, dispersives, textiles, or leather.

10. The method of claim 1 , wherein the cell culture has increased 3-HP production greater than about 40 g/L of biomass/cell culture.

11. The method of claim 1 , wherein the cell culture has increased 3-HP production greater than about 60 g/L of biomass/cell culture.

12. The method of claim 1 , wherein the cell culture has increased 3-HP production greater than about 85 g/L of biomass/cell culture.

13. The method of claim 1 , wherein said genetically modified E. coli microorganism further comprises reduction in activity of a lactate dehydrogenase.

14. The method of claim 1 , wherein said genetically modified E. coli microorganism further comprises reduction in activity of a phosphate acetyltransferase.

15. The method of claim 1 , wherein said genetically modified E. coli microorganism further comprises reduction in activity of a pyruvate oxidase.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2016
From: SILICON VALLEY BANK
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 040746/0051 →
SECURITY INTEREST Recorded Apr 7, 2015
From: OPX BIOTECHNOLOGIES, INC.
To: SILICON VALLEY BANK
Reel/Frame 035350/0608 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2012
From: LYNCH, MICHAEL D.
To: OPX BIOTECHNOLOGIES, INC.
Reel/Frame 028948/0364 →
Continuity (3)
Continuation 12328588 · Dec 4, 2008
Provisional Application 60992290 · Dec 4, 2007
Related Publication 20120041232A1 · Feb 16, 2012